inclusion criteria: - symptoms occurring within 3 days prior to patient presenting to usa facility for pcr nasopharyngeal swab - nasopharyngeal swab positive for covid-19 infection and/or exposure and/or symptoms congruent with fever and cough - male or female age 19 to 89 years - able to take oral medications - patients not requiring hospitalization - provision of informed consent

inclusion criteria: - symptoms occurring within 3 days prior to patient presenting to usa facility for pcr nasopharyngeal swab - nasopharyngeal swab positive for covid-19 infection and/or exposure and/or symptoms congruent with fever and cough - male or female age 19 to 89 years - able to take oral medications - patients not requiring hospitalization - provision of informed consent